Leronlimab (CCR5/CD195) - Research Grade Biosimilar
Product Specifications
Background
Leronlimab (PRO140) is humanized IgG4 monoclonal antibody that can target blocking chemokine receptor 5 (CCR5), which is a cellular receptor that is involved in HIV infection, tumor metastasis, and immune signal transduction Play multiple roles.
Immunogen
Humanized / CCR5/CD195 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
HuPRO-140, PA-14, PRO-140
More Discoveries
Explore Other Products
Browse additional items from our catalog
